C
CERT
Certara, Inc.
5.43
-0.19-3.38%After Hours: 5.43 0.00 0.02%18:31 04/08 EDT
OPEN/PREV CLOSE5.81/5.62
TODAY RANGE5.41-5.90
VOL3.77M
MARKET CAP832.56M
52 WEEK RANGE5.24-15.38
AVG VOL (3M)3.48M
% TURNOVER2.46%
TURNOVER--
P/E (TTM)-548.4848
% RANGE8.72%
EPS(TTM)-0.0099
P/E(FORWARD)181.00
P/B0.8131
BVPS6.68
DIVIDEND--
P/S2.063
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP645.05M
SHARES OUTSTANDING153.33M
NEXT EARNINGS05/04-05/19
FREE FLOAT118.79M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·5d ago
Certara announces annual shareholder meeting webcast
TipRanks·04/01 03:31
Certara Announces Upcoming Board and Audit Committee Change
Reuters·03/31 20:35
Certara director Cynthia Collins to resign effective May 14
Simply Wall St·03/15 21:15
Assessing Certara (CERT) Valuation After FDA PBPK Milestone And New Biosimulation Software Launches
Reuters·03/09 10:23
CERTARA <CERT.O>: BARCLAYS CUTS TO EQUAL-WEIGHT FROM OVERWEIGHT
Reuters·03/09 07:34
U.S. RESEARCH ROUNDUP-Dow, Oracle, Shopify
Simply Wall St·03/09 03:21
How Investors Are Reacting To Certara (CERT) FDA Acceptance Of Simcyp In Place Of Clinical Trials
Simply Wall St·03/08 02:23
Assessing Certara (CERT) Valuation After FDA PBPK Milestone And Latest Earnings Guidance
TipRanks·03/07 17:10
Certara price target lowered to $10 from $15 at UBS
Seeking Alpha·03/06 18:44
Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
Dow Jones·03/06 14:07
Certara Price Target Maintained With a $8.00/Share by Barclays
Dow Jones·03/06 14:07
Certara Cut to Equal-Weight From Overweight by Barclays
Benzinga·03/06 14:00
Forecasting The Future: 7 Analyst Projections For Certara
Benzinga·03/06 13:57
Barclays Downgrades Certara to Equal-Weight, Maintains Price Target to $8
Same Industry
Name/Symbol
Change%
Price